Exhale

The official blog of the Lung Institute.

Lung Institute Supports Pulmonary Fibrosis Awareness Day with Unique Plea to the Public

4 Sep 2013
| Under Press | Posted by | 0 Comments
Pulmonary Fibrosis Awareness Day

On September 7th, at 1 p.m., Hold Your Breath as Long as You Can for Pulmonary Fibrosis Awareness Day

Tampa, FL (September 4, 2013) – In honor of Global Pulmonary Fibrosis Awareness Day, Tampa-based stem cell provider Lung Institute is asking the general public to participate in an event called A Breathless Moment.

When: Saturday, September 7th at 1 p.m.

Why:  The time of 1 p.m. was chosen to represent living with the capacity of only one lung, and the exercise of holding one’s breath as long as possible shows non-sufferers what it feels like to live with this disorder every minute of every day.

Pulmonary Fibrosis Facts:

  • The disease affects approximately 140,000 people in the US.
  • An estimated 50,000 new cases are diagnosed each year, with no known cause.
  • Pulmonary fibrosis can strike anyone, but the disease tends to occur between the ages of 50 and 75.

“Pulmonary fibrosis is a debilitating disease that leaves sufferers with limited options,” said Lynne Flaherty, Director of Operations at the Lung Institute. “At LI, we not only provide innovative treatments that aid in the restoration of damaged lung tissues, we strive to raise awareness about different forms of lung disease, like pulmonary fibrosis.”

About Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 729-3065.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.